Biofilm microenvironment-responsive polymeric CO releasing micelles for enhanced amikacin efficacy

Biofilm-associated infections (BAI) have posed serious threats to public health. Novel therapy based on carbon monoxide (CO) is being increasingly appreciated. However, CO therapy like inhaled gas treatment was impeded owing to its low bioavailability. Besides, the direct use of CO releasing molecul...

Full description

Saved in:
Bibliographic Details
Published in:Journal of controlled release 2023-05, Vol.357, p.561-571
Main Authors: Zhou, Qian, Wang, Tengjiao, Li, Kunpeng, Zhang, Shanyu, Wang, Kun, Hong, Weilin, Liu, Rongjun, Li, Peng
Format: Article
Language:English
Subjects:
Amikacin
Anti-Bacterial Agents - pharmacology
Antibiotic therapy
Biofilm microenvironment
Biofilms
Drug Carriers - chemistry
Gasotransmitter
Micelles
Polymeric micelles
Polymers - chemistry
Self-assembly
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Biofilm-associated infections (BAI) have posed serious threats to public health. Novel therapy based on carbon monoxide (CO) is being increasingly appreciated. However, CO therapy like inhaled gas treatment was impeded owing to its low bioavailability. Besides, the direct use of CO releasing molecules (CORM) showed low therapeutic efficacy in BAI. Therefore, it is vital to improve the efficiency of CO therapy. Herein, we proposed polymeric CO releasing micelles (pCORM) from self-assembly of amphiphilic copolymers containing CORM bearing block as hydrophobic part and acryloylmorpholine block as hydrophilic part. The catechol modified CORM were conjugated through pH cleavable boronate ester bonds and releasing CO passively under biofilm microenvironment. When combined with subminimal inhibitory concentration antibiotic amikacin, pCORM could significantly enhance its bactericidal efficiency against biofilm-encapsulated multidrug-resistant bacteria, representing a promising approach to combat BAI. [Display omitted] •pCORM showed acidic pH/thiol dual-responsive CO release property.•pCORM exhibited BME responsive significantly antibacterial ability.•The combination between pCORM and amikacin displayed noticeably enhanced bactericidal efficacy.
ISSN:0168-3659
1873-4995
DOI:10.1016/j.jconrel.2023.04.025